A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis
Clinical trial NCT03230292 · COMPLETED
Trial details
- NCT number
- NCT03230292
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-03
- Primary completion
- 2019-03-06
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.